Find trials
Search tips

Virtual Reality for Fibromyalgia

Overview

About this study

The purpose of this study is to assess the overall feasibility of virtual reality for the treatment of fibromyalgia and identify problems, issues, or challenges that may impact the performance of a future clinical trial. 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Symptoms of Fibromyalgia
  • Prior positive Fibromyalgia questionnaire to include Widespread Pain Index and Symptom Severity Score
  • Negative exam for alternative rheumatologic disease

Exclusion Criteria: 

  • Initiation of opioid medications within 8 weeks
  • Major concomitant illness
  • Current illicit drug use or alcohol use that that would interfere with adherence to study requirements
  • Symptoms of vertigo or dizziness that would limit tolerability of the VR headset

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 06/17/2024. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Dacre Knight, M.D.

Open for enrollment

Contact information:

Dacre Knight M.D.

(904) 953-2160

Knight.Dacre@mayo.edu

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20582789

Mayo Clinic Footer